# To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee

> **NCT05474586** · NA · COMPLETED · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 236 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **OTHER:** Collavant n2 40 mg/day
- **OTHER:** Glucosamine hydrochloride & Chondroitin sulfate
- **OTHER:** Microcrystalline cellulose

## Key facts

- **NCT ID:** NCT05474586
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-08
- **Primary completion:** 2023-07-04
- **Final completion:** 2023-07-04
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474586, "To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05474586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*